Olivier Pasquier Joins CYTOO as Chief Commercial Officer

News   Mar 18, 2013

 
Olivier Pasquier Joins CYTOO as Chief Commercial Officer
 
 
 

RELATED ARTICLES

Pathway in Neurons may Contribute to Neurodegenerative Disease

News

Pathway has received attention as potential drug target.

READ MORE

Expanded Potential Stem Cells Created

News

Scientists have created Expanded Potential Stem Cells (EPSCs) that, for the first time, can produce all three types of blastocyst stem cells - embryo, placenta and yolk sac.

READ MORE

A New Tactic in the Fight Against Drug-Resistant Infections

News

$1 million research grant could lead to life-saving antibiotics.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE